Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Anebulo Pharmaceuticals Inc fell by 3.30m. Cash Flow from Financing totalled 6.38m or -- of revenues. In addition the company used 9.68m for operations while cash used for investing totalled .
Cash flow per share | -0.0964 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1922 |
---|---|
Tangible book value per share | 0.1922 |
More ▼
Balance sheet in USDView more
Current ratio | 5.32 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼